Search Result
Results for "
PEG2000
" in MedChemExpress (MCE) Product Catalog:
84
Biochemical Assay Reagents
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-Y0873B
-
|
Polyethylene glycol 2000
|
Biochemical Assay Reagents
|
Others
|
|
PEG2000 (Polyethylene glycol 2000) is a solvent for a large number of substances. PEG2000 can be used as a carrier material and modifying agent. PEG2000 is widely used in a variety of pharmaceutical formulations .
|
-
-
- HY-112768
-
|
|
Liposome
|
Others
|
|
PEG2000-DMPE can be used to synthsis a LNP. PEG2000-DMPE enhances the entrapment efficiency depending on the increasing portion in the liposome. The optimal formulation for animal study is that DMPC/PEG2000-DMPE/CH=50/5/45 at the weight ratio of drug/lipid=1/20 .
|
-
-
- HY-145411
-
|
|
Liposome
|
Endocrinology
|
|
PEG2000-C-DMG, a pegylated lipid, can be used for the preparation of Onpattro. Onpattro, a hepatically directed investigational RNAi therapeutic agent, harnesses this process to reduce the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA .
|
-
-
- HY-144005
-
|
C16 PEG Ceramide (MW 2000)
|
Liposome
Autophagy
|
Cancer
|
|
C16 PEG2000 Ceramide is a polyethylene glycolylated ceramide. C16 PEG2000 Ceramide can be used for lipid carrier to delivery. C16 PEG2000 Ceramide induces autophagy. C16 PEG2000 Ceramide can be used for cancer research .
|
-
-
- HY-144012
-
|
16:0 PEG2000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG2000 (16:0 PEG2000 PE) is a PEG-modified lipids. 16:0 PEG2000 PE can reduce the nonspecific adsorption of protein and prolong circulation time in vivo .
|
-
-
- HY-144006
-
|
14:0 PEG2000 PE; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG2000 (14:0 PEG2000 PE) is a PEG-phospholipid conjugate to prepare nanostructured lipid carrier .
|
-
-
- HY-144010
-
|
DOPE-PEG2000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Liposome
|
Others
|
|
18:1 PEG2000 PE (18:1 PEG-PE) is a polyethyleneglycol/phosphatidyl-ethanolamine conjugate. 18:1 PEG2000 PE can be used for drug delivery .
|
-
-
- HY-112756
-
|
|
Liposome
|
Others
|
|
PEG2000-DGG is a synthetic lipid. PEG2000-DGG can be used in lipid-based nanoparticle (LNP) delivery systems .
|
-
-
- HY-167371
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA5000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA5000-PEG2000-BIO can be used in drug delivery research .
|
-
-
- HY-167374
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA4000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA4000-PEG2000-BIO can be used in drug delivery research .
|
-
-
- HY-167377
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA3000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA3000-PEG2000-BIO can be used in drug delivery research .
|
-
-
- HY-167380
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA2000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA2000-PEG2000-BIO can be used in drug delivery research .
|
-
-
- HY-167383
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA1000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA1000-PEG2000-BIO can be used in drug delivery research .
|
-
-
- HY-167386
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA10000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA10000-PEG2000-BIO can be used in drug delivery research .
|
-
-
- HY-167005
-
|
PLGA10000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLGA10000-PEG2000-VS (PLGA10000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167009
-
|
PLGA1000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLGA1000-PEG2000-VS (PLGA1000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167017
-
|
PLGA2000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLGA2000-PEG2000-VS (PLGA2000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167023
-
|
PLGA3000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLGA3000-PEG2000-VS (PLGA3000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167030
-
|
PLGA4000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLGA4000-PEG2000-VS (PLGA4000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167035
-
|
PLGA5000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLGA5000-PEG2000-VS (PLGA5000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167042
-
|
PLLA10000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-VS (PLLA10000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167044
-
|
PLLA5000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-VS (PLLA5000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167048
-
|
PLLA1000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-VS (PLLA1000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167054
-
|
PLLA2000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-VS (PLLA2000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167055
-
|
PLLA4000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-VS (PLLA4000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167059
-
|
PLLA3000-PEG2000-Vinylsulfone
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-VS (PLLA3000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
-
- HY-167390
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA5000-PEG2000-ALK can be used in drug delivery research .
|
-
-
- HY-167394
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA4000-PEG2000-ALK can be used in drug delivery research .
|
-
-
- HY-167398
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA3000-PEG2000-ALK can be used in drug delivery research .
|
-
-
- HY-167402
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA2000-PEG2000-ALK can be used in drug delivery research .
|
-
-
- HY-167406
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA1000-PEG2000-ALK can be used in drug delivery research .
|
-
-
- HY-167410
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA10000-PEG2000-ALK can be used in drug delivery research .
|
-
-
- HY-140739
-
|
|
Liposome
|
Others
|
|
DSPE-PEG2000-Maleimide is a PEG compound which composed of DSPE and maleimide groups. DSPE-PEG2000-Maleimide can be used for compose liposomes .
|
-
-
- HY-167471
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167475
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167479
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167483
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167487
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167491
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167296
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA5000-PEG2000-Thiol can be used in drug delivery research .
|
-
-
- HY-167300
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA4000-PEG2000-Thiol can be used in drug delivery research .
|
-
-
- HY-167304
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA3000-PEG2000-Thiol can be used in drug delivery research .
|
-
-
- HY-167308
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA2000-PEG2000-Thiol can be used in drug delivery research .
|
-
-
- HY-167312
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA1000-PEG2000-Thiol can be used in drug delivery research .
|
-
-
- HY-167316
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA10000-PEG2000-Thiol can be used in drug delivery research .
|
-
-
- HY-167320
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA5000-PEG2000-SPDP can be used in drug delivery research .
|
-
-
- HY-167324
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA4000-PEG2000-SPDP can be used in drug delivery research .
|
-
-
- HY-167328
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA3000-PEG2000-SPDP can be used in drug delivery research .
|
-
-
- HY-167332
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA2000-PEG2000-SPDP can be used in drug delivery research .
|
-
-
- HY-167336
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA1000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167340
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA10000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167412
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-FOL is a polylactic acid derivative. Polylactic acid derivatives have strong binding affinity to folate receptors and clear biodegradability. PLLA5000-PEG2000-FOL can be used in drug delivery research .
|
-
- HY-167414
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA20000-PEG2000-FOL is a polylactic acid derivative. Polylactic acid derivatives have strong binding affinity to folate receptors and clear biodegradability. PLLA20000-PEG2000-FOL can be used in drug delivery research .
|
-
- HY-167416
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-FOL is a polylactic acid derivative. Polylactic acid derivatives have strong binding affinity to folate receptors and clear biodegradability. PLLA10000-PEG2000-FOL can be used in drug delivery research .
|
-
- HY-167445
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA5000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167449
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA4000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167453
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA3000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167457
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA2000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167461
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA1000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167465
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA10000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167419
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA5000-PEG2000-NH2 can be used in drug delivery research .
|
-
- HY-167423
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA4000-PEG2000-NH2 can be used in drug delivery research .
|
-
- HY-167427
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA3000-PEG2000-NH2 can be used in drug delivery research .
|
-
- HY-167432
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA2000-PEG2000-NH2 can be used in drug delivery research .
|
-
- HY-167437
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA1000-PEG2000-NH2 can be used in drug delivery research .
|
-
- HY-167441
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA10000-PEG2000-NH2 can be used in drug delivery research .
|
-
- HY-D2373
-
|
|
Fluorescent Dye
|
Others
|
|
CY5.5-PEG2000-Mal is used for preparing fluorescently labeled molecules. It is formed by condensing maleimide groups (Mal), PEG2000, and fluorescent dye CY5.5 (HY-D0924) .
|
-
- HY-145396B
-
-
- HY-167344
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-PLLA5000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA5000-PEG2000-PLLA5000 can be used in drug delivery research .
|
-
- HY-167350
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-PLLA4000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA4000-PEG2000-PLLA4000 can be used in drug delivery research .
|
-
- HY-167356
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-PLLA3000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA3000-PEG2000-PLLA3000 can be used in drug delivery research .
|
-
- HY-167362
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-PLLA2000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA2000-PEG2000-PLLA2000 can be used in drug delivery research .
|
-
- HY-167368
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-PLLA1000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA1000-PEG2000-PLLA1000 can be used in drug delivery research .
|
-
- HY-167138
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA8000-PEG2000-PLLA8000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA8000-PEG2000-PLLA8000 can be used in drug delivery research .
|
-
- HY-167124
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA6000-PEG2000-PLLA6000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA6000-PEG2000-PLLA6000 can be used in drug delivery research .
|
-
- HY-159194
-
|
|
Liposome
|
Cancer
|
|
DSPE-PEG2000-Cy5.5 is a CY5.5 labeled DSPE-PEG 2000 for drug delivery and imaging .
|
-
- HY-112764
-
DMG-PEG 2000
Maximum Cited Publications
8 Publications Verification
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 is used?for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the?lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-142979
-
|
|
Liposome
|
Others
|
|
DSPE-PEG 2000 is a PEG-lipid that can be used to form micelles as nanoparticles for drug delivery .
|
-
- HY-141892A
-
|
DSPE PEG(2000) Carboxylic Acid sodium
|
Liposome
|
Others
|
|
DSPE-PEG Carboxylic acid (sodium), MW 2000 is a PEG-lipid that can be used to form micelles as nanoparticles for drug delivery. DSPE-PEG Carboxylic acid (sodium), MW 2000 increases the blood circulation time of liposomes .
|
-
- HY-W591381
-
|
DSG-PEG 2000
|
Liposome
|
Others
|
|
DSG-PEG is a type of polyethylene glycol grease. DSG-PEG can be used to prepare liposomes .
|
-
- HY-157950
-
|
|
Liposome
|
Cancer
|
|
DSPE-PEG2K-triGalNAc is a polar lipid composed of DSPE and tri-N-acetylgalactosamine that can be used to construct liposomes target to asialoglycoprotein receptor (ASGPR).
|
-
- HY-D1005A8
-
|
PEG-PPG-PEG, 2000 (Averag)
|
Biochemical Assay Reagents
Bacterial
|
Infection
|
|
Poloxamer 181 L61 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2000. Poloxamer 181 L61 exhibits antimicrobial activity, that inihibits 91% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 181 L61 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering .
|
-
- HY-160573
-
|
|
Liposome
|
Others
|
|
cKK-E15 is a peptide-lipid that can be used to formulate LNP3 with C14PEG2000, unmodified cholesterol, and DOPE .
|
-
- HY-144004
-
|
DSPE-PEG2000 Maleimide ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] ammonium
|
Liposome
|
Others
|
|
DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents .
|
-
- HY-140736
-
|
DSPE-PEG(2000) Biotin
|
Liposome
PROTAC Linkers
|
Cancer
|
|
DSPE-PEG-Biotin, MW 2000 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W440832
-
|
DSPE-PEG(2000) Azide
|
Liposome
|
Infection
|
|
DSPE-PEG-Azide (MW 2000) is an azide containing lipid that can be used to form micelles as nanoparticles for drug delivery . DSPE-PEG-Azide (MW 2000) is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
|
-
- HY-W440888
-
|
DSPE-PEG(2000) Folate
|
Liposome
|
Others
|
|
DSPE-PEG-Folate, MW 2000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 2000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 2000 form micelles/lipid bilayer and can be used to targeted drug delivery system research.
|
-
- HY-W440835
-
|
DSPE-PEG(2000)-DBCO
|
Liposome
|
Others
|
|
DSPE-PEG-DBCO, MW 2000 is a phospholipid-PEG polymer that can be used to form micelles as lipid nanoparticles for drug delivery . DSPE-PEG-DBCO, MW 2000 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-W441014
-
|
DSPE-PEG2000-NHS
|
Liposome
|
Others
|
|
DSPE-PEG-NHS, MW 2000 is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine.
|
-
- HY-169232
-
|
|
PROTACs
|
Cancer
|
|
PCC16 chloride is a CRBN-based cp-PCC with an IC50 value of 102 nM for the degradation of DHHC3. PCC16 chloride has antitumor activity. (Target protein ligand: HY-169235, linker: HY-169236, E3 ligase ligand: HY-10984) .
|
-
- HY-125924
-
|
DSPE-PEG-NH2, MW 2000 ammonium; DSPE-PEG(2000) Amine ammonium
|
Liposome
|
Others
|
|
DSPE-PEG-Amine, MW 2000 (ammonium), an amine derivative of phospholipid poly ethylene glycol, is used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents .
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-D2373
-
|
|
Dyes
|
|
CY5.5-PEG2000-Mal is used for preparing fluorescently labeled molecules. It is formed by condensing maleimide groups (Mal), PEG2000, and fluorescent dye CY5.5 (HY-D0924) .
|
-
- HY-159194
-
| Cat. No. |
Product Name |
Type |
-
- HY-112768
-
|
|
Drug Delivery
|
|
PEG2000-DMPE can be used to synthsis a LNP. PEG2000-DMPE enhances the entrapment efficiency depending on the increasing portion in the liposome. The optimal formulation for animal study is that DMPC/PEG2000-DMPE/CH=50/5/45 at the weight ratio of drug/lipid=1/20 .
|
-
- HY-145411
-
|
|
Drug Delivery
|
|
PEG2000-C-DMG, a pegylated lipid, can be used for the preparation of Onpattro. Onpattro, a hepatically directed investigational RNAi therapeutic agent, harnesses this process to reduce the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA .
|
-
- HY-144005
-
|
C16 PEG Ceramide (MW 2000)
|
Drug Delivery
|
|
C16 PEG2000 Ceramide is a polyethylene glycolylated ceramide. C16 PEG2000 Ceramide can be used for lipid carrier to delivery. C16 PEG2000 Ceramide induces autophagy. C16 PEG2000 Ceramide can be used for cancer research .
|
-
- HY-144012
-
|
16:0 PEG2000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Drug Delivery
|
|
DPPE-PEG2000 (16:0 PEG2000 PE) is a PEG-modified lipids. 16:0 PEG2000 PE can reduce the nonspecific adsorption of protein and prolong circulation time in vivo .
|
-
- HY-144006
-
|
14:0 PEG2000 PE; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Drug Delivery
|
|
DMPE-PEG2000 (14:0 PEG2000 PE) is a PEG-phospholipid conjugate to prepare nanostructured lipid carrier .
|
-
- HY-144010
-
|
DOPE-PEG2000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Drug Delivery
|
|
18:1 PEG2000 PE (18:1 PEG-PE) is a polyethyleneglycol/phosphatidyl-ethanolamine conjugate. 18:1 PEG2000 PE can be used for drug delivery .
|
-
- HY-112756
-
|
|
Drug Delivery
|
|
PEG2000-DGG is a synthetic lipid. PEG2000-DGG can be used in lipid-based nanoparticle (LNP) delivery systems .
|
-
- HY-167371
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA5000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA5000-PEG2000-BIO can be used in drug delivery research .
|
-
- HY-167374
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA4000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA4000-PEG2000-BIO can be used in drug delivery research .
|
-
- HY-167377
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA3000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA3000-PEG2000-BIO can be used in drug delivery research .
|
-
- HY-167380
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA2000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA2000-PEG2000-BIO can be used in drug delivery research .
|
-
- HY-167383
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA1000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA1000-PEG2000-BIO can be used in drug delivery research .
|
-
- HY-167386
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-BIO is a polylactic acid derivative that can form micelles in water. In addition, PLLA10000-PEG2000-BIO can bind tightly to avidin or streptavidin for protein labeling. PLLA10000-PEG2000-BIO can be used in drug delivery research .
|
-
- HY-167005
-
|
PLGA10000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLGA10000-PEG2000-VS (PLGA10000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167009
-
|
PLGA1000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLGA1000-PEG2000-VS (PLGA1000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167017
-
|
PLGA2000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLGA2000-PEG2000-VS (PLGA2000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167023
-
|
PLGA3000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLGA3000-PEG2000-VS (PLGA3000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167030
-
|
PLGA4000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLGA4000-PEG2000-VS (PLGA4000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167035
-
|
PLGA5000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLGA5000-PEG2000-VS (PLGA5000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167042
-
|
PLLA10000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLLA10000-PEG2000-VS (PLLA10000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167044
-
|
PLLA5000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLLA5000-PEG2000-VS (PLLA5000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167048
-
|
PLLA1000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLLA1000-PEG2000-VS (PLLA1000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167054
-
|
PLLA2000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLLA2000-PEG2000-VS (PLLA2000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167055
-
|
PLLA4000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLLA4000-PEG2000-VS (PLLA4000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167059
-
|
PLLA3000-PEG2000-Vinylsulfone
|
Drug Delivery
|
|
PLLA3000-PEG2000-VS (PLLA3000-PEG2000-Vinylsulfone) is an amphiphilic polymer. Amphiphilic polymers can be used in drug delivery studies due to their ability to self-assemble into discrete aggregates .
|
-
- HY-167390
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA5000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167394
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA4000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167398
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA3000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167402
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA2000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167406
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA1000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167410
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA10000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-140739
-
|
|
Drug Delivery
|
|
DSPE-PEG2000-Maleimide is a PEG compound which composed of DSPE and maleimide groups. DSPE-PEG2000-Maleimide can be used for compose liposomes .
|
-
- HY-167471
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167475
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167479
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167483
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167487
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167491
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167296
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA5000-PEG2000-Thiol can be used in drug delivery research .
|
-
- HY-167300
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA4000-PEG2000-Thiol can be used in drug delivery research .
|
-
- HY-167304
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA3000-PEG2000-Thiol can be used in drug delivery research .
|
-
- HY-167308
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA2000-PEG2000-Thiol can be used in drug delivery research .
|
-
- HY-167312
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA1000-PEG2000-Thiol can be used in drug delivery research .
|
-
- HY-167316
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-Thiol is a polylactic acid derivative that forms micelles in water and initiates biodegradation by attacking ester bonds through hydrolysis. PLLA10000-PEG2000-Thiol can be used in drug delivery research .
|
-
- HY-167320
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA5000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167324
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA4000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167328
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA3000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167332
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA2000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167336
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA1000-PEG2000-SPDP can be used in drug delivery research .
|
-
- HY-167340
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-SPDP is a polylactic acid derivative that can form micelles in water and the SPDP moiety can react with thiols. PLLA10000-PEG2000-SPDP can be used in drug delivery research .
|
- HY-167412
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-FOL is a polylactic acid derivative. Polylactic acid derivatives have strong binding affinity to folate receptors and clear biodegradability. PLLA5000-PEG2000-FOL can be used in drug delivery research .
|
- HY-167414
-
|
|
Drug Delivery
|
|
PLLA20000-PEG2000-FOL is a polylactic acid derivative. Polylactic acid derivatives have strong binding affinity to folate receptors and clear biodegradability. PLLA20000-PEG2000-FOL can be used in drug delivery research .
|
- HY-167416
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-FOL is a polylactic acid derivative. Polylactic acid derivatives have strong binding affinity to folate receptors and clear biodegradability. PLLA10000-PEG2000-FOL can be used in drug delivery research .
|
- HY-167445
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA5000-PEG2000-N3 can be used in drug delivery research .
|
- HY-167449
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA4000-PEG2000-N3 can be used in drug delivery research .
|
- HY-167453
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA3000-PEG2000-N3 can be used in drug delivery research .
|
- HY-167457
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA2000-PEG2000-N3 can be used in drug delivery research .
|
- HY-167461
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA1000-PEG2000-N3 can be used in drug delivery research .
|
- HY-167465
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA10000-PEG2000-N3 can be used in drug delivery research .
|
- HY-167419
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA5000-PEG2000-NH2 can be used in drug delivery research .
|
- HY-167423
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA4000-PEG2000-NH2 can be used in drug delivery research .
|
- HY-167427
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA3000-PEG2000-NH2 can be used in drug delivery research .
|
- HY-167432
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA2000-PEG2000-NH2 can be used in drug delivery research .
|
- HY-167437
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA1000-PEG2000-NH2 can be used in drug delivery research .
|
- HY-167441
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-NH2 is a block copolymer based on polylactic acid derivatives that can self-assemble in water. PLLA10000-PEG2000-NH2 can be used in drug delivery research .
|
- HY-145396B
-
- HY-167344
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-PLLA5000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA5000-PEG2000-PLLA5000 can be used in drug delivery research .
|
- HY-167350
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-PLLA4000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA4000-PEG2000-PLLA4000 can be used in drug delivery research .
|
- HY-167356
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-PLLA3000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA3000-PEG2000-PLLA3000 can be used in drug delivery research .
|
- HY-167362
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-PLLA2000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA2000-PEG2000-PLLA2000 can be used in drug delivery research .
|
- HY-167368
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-PLLA1000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA1000-PEG2000-PLLA1000 can be used in drug delivery research .
|
- HY-167138
-
|
|
Drug Delivery
|
|
PLLA8000-PEG2000-PLLA8000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA8000-PEG2000-PLLA8000 can be used in drug delivery research .
|
- HY-167124
-
|
|
Drug Delivery
|
|
PLLA6000-PEG2000-PLLA6000 is an amphiphilic triblock polymer based on polylactic acid derivatives that improves the specificity and cell affinity of PLA-based biomaterials. PLLA6000-PEG2000-PLLA6000 can be used in drug delivery research .
|
- HY-112764
-
DMG-PEG 2000
Maximum Cited Publications
8 Publications Verification
|
Drug Delivery
|
|
DMG-PEG 2000 is used?for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the?lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
- HY-142979
-
|
|
Drug Delivery
|
|
DSPE-PEG 2000 is a PEG-lipid that can be used to form micelles as nanoparticles for drug delivery .
|
- HY-141892A
-
|
DSPE PEG(2000) Carboxylic Acid sodium
|
Drug Delivery
|
|
DSPE-PEG Carboxylic acid (sodium), MW 2000 is a PEG-lipid that can be used to form micelles as nanoparticles for drug delivery. DSPE-PEG Carboxylic acid (sodium), MW 2000 increases the blood circulation time of liposomes .
|
- HY-D1005A8
-
|
PEG-PPG-PEG, 2000 (Averag)
|
Co-solvents
|
|
Poloxamer 181 L61 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2000. Poloxamer 181 L61 exhibits antimicrobial activity, that inihibits 91% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 181 L61 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering .
|
- HY-144004
-
|
DSPE-PEG2000 Maleimide ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] ammonium
|
Drug Delivery
|
|
DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents .
|
- HY-140736
-
|
DSPE-PEG(2000) Biotin
|
Drug Delivery
|
|
DSPE-PEG-Biotin, MW 2000 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
- HY-W440832
-
|
DSPE-PEG(2000) Azide
|
Drug Delivery
|
|
DSPE-PEG-Azide (MW 2000) is an azide containing lipid that can be used to form micelles as nanoparticles for drug delivery . DSPE-PEG-Azide (MW 2000) is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
|
- HY-W440888
-
|
DSPE-PEG(2000) Folate
|
Drug Delivery
|
|
DSPE-PEG-Folate, MW 2000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 2000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 2000 form micelles/lipid bilayer and can be used to targeted drug delivery system research.
|
- HY-W440835
-
|
DSPE-PEG(2000)-DBCO
|
Drug Delivery
|
|
DSPE-PEG-DBCO, MW 2000 is a phospholipid-PEG polymer that can be used to form micelles as lipid nanoparticles for drug delivery . DSPE-PEG-DBCO, MW 2000 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-W441014
-
|
DSPE-PEG2000-NHS
|
Drug Delivery
|
|
DSPE-PEG-NHS, MW 2000 is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine.
|
- HY-125924
-
|
DSPE-PEG-NH2, MW 2000 ammonium; DSPE-PEG(2000) Amine ammonium
|
Drug Delivery
|
|
DSPE-PEG-Amine, MW 2000 (ammonium), an amine derivative of phospholipid poly ethylene glycol, is used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents .
|
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-169232
-
|
|
PROTACs
|
Cancer
|
|
PCC16 chloride is a CRBN-based cp-PCC with an IC50 value of 102 nM for the degradation of DHHC3. PCC16 chloride has antitumor activity. (Target protein ligand: HY-169235, linker: HY-169236, E3 ligase ligand: HY-10984) .
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-167390
-
|
|
|
Alkynes
|
|
PLLA5000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA5000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167394
-
|
|
|
Alkynes
|
|
PLLA4000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA4000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167398
-
|
|
|
Alkynes
|
|
PLLA3000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA3000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167402
-
|
|
|
Alkynes
|
|
PLLA2000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA2000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167406
-
|
|
|
Alkynes
|
|
PLLA1000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA1000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167410
-
|
|
|
Alkynes
|
|
PLLA10000-PEG2000-ALK is a polylactic acid derivative that can form micelles in water. PLLA10000-PEG2000-ALK can be used in drug delivery research .
|
-
- HY-167445
-
|
|
|
Azide
|
|
PLLA5000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA5000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167449
-
|
|
|
Azide
|
|
PLLA4000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA4000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167453
-
|
|
|
Azide
|
|
PLLA3000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA3000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167457
-
|
|
|
Azide
|
|
PLLA2000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA2000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167461
-
|
|
|
Azide
|
|
PLLA1000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA1000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-167465
-
|
|
|
Azide
|
|
PLLA10000-PEG2000-N3 is a polylactic acid derivative used for encapsulating hydrophobic drugs. PLLA10000-PEG2000-N3 can be used in drug delivery research .
|
-
- HY-W440832
-
|
DSPE-PEG(2000) Azide
|
|
Azide
|
|
DSPE-PEG-Azide (MW 2000) is an azide containing lipid that can be used to form micelles as nanoparticles for drug delivery . DSPE-PEG-Azide (MW 2000) is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
|
-
- HY-W440835
-
|
DSPE-PEG(2000)-DBCO
|
|
DBCO
|
|
DSPE-PEG-DBCO, MW 2000 is a phospholipid-PEG polymer that can be used to form micelles as lipid nanoparticles for drug delivery . DSPE-PEG-DBCO, MW 2000 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-112768
-
|
|
|
Pegylated Lipids
|
|
PEG2000-DMPE can be used to synthsis a LNP. PEG2000-DMPE enhances the entrapment efficiency depending on the increasing portion in the liposome. The optimal formulation for animal study is that DMPC/PEG2000-DMPE/CH=50/5/45 at the weight ratio of drug/lipid=1/20 .
|
-
- HY-145411
-
|
|
|
Pegylated Lipids
|
|
PEG2000-C-DMG, a pegylated lipid, can be used for the preparation of Onpattro. Onpattro, a hepatically directed investigational RNAi therapeutic agent, harnesses this process to reduce the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA .
|
-
- HY-144005
-
|
C16 PEG Ceramide (MW 2000)
|
|
Pegylated Lipids
|
|
C16 PEG2000 Ceramide is a polyethylene glycolylated ceramide. C16 PEG2000 Ceramide can be used for lipid carrier to delivery. C16 PEG2000 Ceramide induces autophagy. C16 PEG2000 Ceramide can be used for cancer research .
|
-
- HY-144012
-
|
16:0 PEG2000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG2000 (16:0 PEG2000 PE) is a PEG-modified lipids. 16:0 PEG2000 PE can reduce the nonspecific adsorption of protein and prolong circulation time in vivo .
|
-
- HY-144006
-
|
14:0 PEG2000 PE; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG2000 (14:0 PEG2000 PE) is a PEG-phospholipid conjugate to prepare nanostructured lipid carrier .
|
-
- HY-144010
-
|
DOPE-PEG2000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
|
Pegylated Lipids
|
|
18:1 PEG2000 PE (18:1 PEG-PE) is a polyethyleneglycol/phosphatidyl-ethanolamine conjugate. 18:1 PEG2000 PE can be used for drug delivery .
|
-
- HY-140739
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG2000-Maleimide is a PEG compound which composed of DSPE and maleimide groups. DSPE-PEG2000-Maleimide can be used for compose liposomes .
|
-
- HY-112764
-
DMG-PEG 2000
Maximum Cited Publications
8 Publications Verification
|
|
Pegylated Lipids
|
|
DMG-PEG 2000 is used?for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the?lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-142979
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG 2000 is a PEG-lipid that can be used to form micelles as nanoparticles for drug delivery .
|
-
- HY-112756
-
|
|
|
Pegylated Lipids
|
|
PEG2000-DGG is a synthetic lipid. PEG2000-DGG can be used in lipid-based nanoparticle (LNP) delivery systems .
|
-
- HY-141892A
-
|
DSPE PEG(2000) Carboxylic Acid sodium
|
|
Pegylated Lipids
|
|
DSPE-PEG Carboxylic acid (sodium), MW 2000 is a PEG-lipid that can be used to form micelles as nanoparticles for drug delivery. DSPE-PEG Carboxylic acid (sodium), MW 2000 increases the blood circulation time of liposomes .
|
-
- HY-W591381
-
|
DSG-PEG 2000
|
|
Pegylated Lipids
|
|
DSG-PEG is a type of polyethylene glycol grease. DSG-PEG can be used to prepare liposomes .
|
-
- HY-157950
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG2K-triGalNAc is a polar lipid composed of DSPE and tri-N-acetylgalactosamine that can be used to construct liposomes target to asialoglycoprotein receptor (ASGPR).
|
-
- HY-160573
-
|
|
|
Cationic Lipids
|
|
cKK-E15 is a peptide-lipid that can be used to formulate LNP3 with C14PEG2000, unmodified cholesterol, and DOPE .
|
-
- HY-144004
-
|
DSPE-PEG2000 Maleimide ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] ammonium
|
|
Pegylated Lipids
|
|
DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents .
|
-
- HY-140736
-
|
DSPE-PEG(2000) Biotin
|
|
Pegylated Lipids
|
|
DSPE-PEG-Biotin, MW 2000 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W440832
-
|
DSPE-PEG(2000) Azide
|
|
Pegylated Lipids
|
|
DSPE-PEG-Azide (MW 2000) is an azide containing lipid that can be used to form micelles as nanoparticles for drug delivery . DSPE-PEG-Azide (MW 2000) is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
|
-
- HY-W440888
-
|
DSPE-PEG(2000) Folate
|
|
Pegylated Lipids
|
|
DSPE-PEG-Folate, MW 2000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 2000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 2000 form micelles/lipid bilayer and can be used to targeted drug delivery system research.
|
-
- HY-W440835
-
|
DSPE-PEG(2000)-DBCO
|
|
Pegylated Lipids
|
|
DSPE-PEG-DBCO, MW 2000 is a phospholipid-PEG polymer that can be used to form micelles as lipid nanoparticles for drug delivery . DSPE-PEG-DBCO, MW 2000 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-W441014
-
|
DSPE-PEG2000-NHS
|
|
Pegylated Lipids
|
|
DSPE-PEG-NHS, MW 2000 is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine.
|
-
- HY-125924
-
|
DSPE-PEG-NH2, MW 2000 ammonium; DSPE-PEG(2000) Amine ammonium
|
|
Pegylated Lipids
|
|
DSPE-PEG-Amine, MW 2000 (ammonium), an amine derivative of phospholipid poly ethylene glycol, is used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent:
